Preventing Potential Patient Harm Through Clinical Content Interventions During Oncology Clinical Trial Implementation
Open Access
- 25 August 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Patient Safety
- Vol. 19 (7) , 460-464
Abstract
Objectives: Clinical trial documents are complex and may have inconsistencies, leading to potential site implementation errors and may compromise participant safety. This study characterizes the frequency and type of administrative and potential patient safety interventions (PPSIs) made during the review of oncology trial documents for clinical trial implementation by centralized clinical content specialists. Methods: A dedicated group of centralized clinical content specialists reviewed trial documents, including the protocol, laboratory manual, and pharmacy/cellular therapy manual, and collected intervention data over a 1-year period. Each trial was categorized by study phase and sponsor type, and multiple interventions could be identified per trial. Interventions were deemed administrative or PPSIs, with PPSIs further subcategorized as medication, laboratory, procedure related, or other. Results: Of 585 clinical trials reviewed, 269 (46%) required intervention(s). Among 1001 interventions, 171 (17.1%) were PPSIs. Most PPSIs were medication related (45.6%), with drug dosing interventions most frequently identified (53.8%). Phase 1 trials had the highest proportion of PPSIs (0.35:1) and administrative interventions (2:1) per trial compared with all other phases. Investigator-initiated trials saw the highest proportion of PPSIs per trial (0.44:1) of all sponsor types. Conclusions: This study demonstrates a gap in patient safety when assessing trial documents for clinical trial implementation. One solution to address this gap is the utilization of a centralized team of clinical specialists to preemptively review trial documents, thereby enhancing patient safety during clinical trial conduct.Keywords
This publication has 14 references indexed in Scilit:
- Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC)Drug Safety, 2019
- Investigator-initiated studies: Challenges and solutionsPerspectives in Clinical Research, 2018
- The impact of health information technology on patient safetySaudi Medical Journal, 2017
- Evidence-Based Guidelines to Eliminate Repetitive Laboratory TestingJAMA Internal Medicine, 2017
- Assessment and classification of protocol deviationsPerspectives in Clinical Research, 2016
- Ensuring Participant Safety and Trial Integrity With Clinical Trials OversightJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- Serious safety events: Getting to Zero™Journal of Healthcare Risk Management, 2013
- Protocol deviation and violationPerspectives in Clinical Research, 2012
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009
- American Society of Clinical Oncology Statement on Minimum Standards and Exemplary Attributes of Clinical Trial SitesJournal of Clinical Oncology, 2008